HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Han Liu Selected Research

N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazide

1/2020Dynasore potentiates c-Met inhibitors against hepatocellular carcinoma through destabilizing c-Met.
12/2018Dynasore-induced potent ubiquitylation of the exon 19 deletion mutant of epidermal growth factor receptor suppresses cell growth and migration in non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Han Liu Research Topics

Disease

112Neoplasms (Cancer)
11/2022 - 12/2008
41Inflammation (Inflammations)
10/2022 - 05/2010
28Infections
01/2022 - 04/2009
24Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 01/2011
22Neoplasm Metastasis (Metastasis)
08/2022 - 01/2012
13Carcinogenesis
05/2022 - 01/2012
12Lung Neoplasms (Lung Cancer)
11/2021 - 03/2013
10Hypoxia (Hypoxemia)
06/2022 - 06/2013
10Carcinoma (Carcinomatosis)
04/2022 - 01/2016
10Leukemia
04/2022 - 01/2007
10Wounds and Injuries (Trauma)
10/2021 - 01/2014
10Adenocarcinoma
01/2021 - 10/2016
9Traumatic Brain Injuries (Traumatic Brain Injury)
08/2022 - 01/2016
9Sepsis (Septicemia)
01/2022 - 01/2015
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2021 - 08/2015
8Stomach Neoplasms (Stomach Cancer)
06/2022 - 02/2017
8Breast Neoplasms (Breast Cancer)
01/2020 - 02/2012
8Pain (Aches)
10/2018 - 12/2009
7Thrombosis (Thrombus)
01/2022 - 03/2019
7Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 11/2017
6Reperfusion Injury
06/2022 - 01/2016
6Hepatocellular Carcinoma (Hepatoma)
01/2022 - 06/2009
6Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022 - 04/2013
6Pathologic Constriction (Stenosis)
01/2022 - 03/2019
6Neuralgia (Stump Neuralgia)
10/2020 - 02/2010
5Gallbladder Neoplasms (Gallbladder Cancer)
05/2022 - 01/2020
5Parkinson Disease (Parkinson's Disease)
12/2021 - 12/2017
5Fibrosis (Cirrhosis)
07/2021 - 05/2017
5Hyperalgesia
10/2020 - 12/2009
5Necrosis
03/2019 - 06/2015
5Hyperglycemia
08/2012 - 01/2011
5Prostatic Neoplasms (Prostate Cancer)
01/2012 - 12/2008
4Adenocarcinoma of Lung
08/2022 - 05/2019
4Lymphoma (Lymphomas)
05/2022 - 04/2013
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2022 - 01/2018
4Pancreatitis
01/2022 - 02/2013
4Atherosclerosis
01/2022 - 09/2009
4Cholangiocarcinoma
01/2022 - 01/2017
4Colitis
01/2022 - 01/2015
4COVID-19
01/2022 - 01/2020
4Arthritis (Polyarthritis)
01/2021 - 08/2018
4Myocardial Ischemia (Ischemic Heart Diseases)
01/2021 - 01/2014
4Melanoma (Melanoma, Malignant)
01/2020 - 12/2013
4Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 10/2014
4Colonic Neoplasms (Colon Cancer)
01/2020 - 02/2017
3Ovarian Neoplasms (Ovarian Cancer)
05/2022 - 12/2015
3Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022 - 01/2021
3Heart Failure
10/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

51Proteins (Proteins, Gene)FDA Link
05/2022 - 01/2007
21Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2012
19CytokinesIBA
05/2022 - 08/2012
19Biological ProductsIBA
01/2022 - 07/2009
15Long Noncoding RNAIBA
08/2022 - 01/2016
14Messenger RNA (mRNA)IBA
03/2021 - 12/2009
13Pharmaceutical PreparationsIBA
05/2022 - 10/2014
13Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2012
12MicroRNAs (MicroRNA)IBA
12/2021 - 10/2014
11Glucose (Dextrose)FDA LinkGeneric
08/2022 - 01/2011
9Small Interfering RNA (siRNA)IBA
01/2021 - 09/2012
8Interleukin-17 (Interleukin 17)IBA
01/2022 - 01/2016
7Oxygen (Dioxygen)IBA
08/2022 - 04/2013
7Therapeutic UsesIBA
12/2021 - 10/2017
6RNA (Ribonucleic Acid)IBA
01/2022 - 01/2018
6DNA (Deoxyribonucleic Acid)IBA
01/2021 - 04/2014
6Peptides (Polypeptides)IBA
01/2021 - 01/2014
6Sirtuin 1IBA
10/2020 - 10/2017
6Dual OxidasesIBA
11/2019 - 02/2013
6NADPH Oxidases (NAD(P)H oxidase)IBA
11/2017 - 02/2013
5InterleukinsIBA
01/2022 - 01/2015
5AntioxidantsIBA
01/2022 - 05/2014
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 08/2018
5GemcitabineFDA Link
12/2021 - 08/2011
5SynucleinsIBA
12/2021 - 01/2020
5Proteasome InhibitorsIBA
06/2021 - 04/2014
5Bexarotene (LGD1069)FDA Link
12/2020 - 01/2017
5Purinergic P2X3 ReceptorsIBA
10/2020 - 12/2009
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 10/2010
5LipidsIBA
03/2020 - 01/2018
5ErbB Receptors (EGF Receptor)IBA
12/2018 - 01/2013
4LipopolysaccharidesIBA
01/2022 - 02/2013
4Caspase 3 (Caspase-3)IBA
10/2021 - 06/2009
4Transcription Factors (Transcription Factor)IBA
01/2021 - 12/2017
4CateninsIBA
01/2021 - 02/2011
4Emodin (Archin)IBA
01/2021 - 04/2011
4puerarinIBA
10/2020 - 12/2009
4Protein Isoforms (Isoforms)IBA
12/2018 - 06/2014
4Estrogen ReceptorsIBA
01/2018 - 01/2013
4LigandsIBA
06/2013 - 01/2011
3Immune Checkpoint InhibitorsIBA
11/2022 - 01/2021
3ChemokinesIBA
05/2022 - 08/2015
3Caspase 8 (Caspase-8)IBA
01/2022 - 04/2014
3nickel monoxide (nickel oxide)IBA
01/2022 - 01/2021
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2014
3AntibodiesIBA
10/2021 - 04/2013
3Etanercept (Enbrel)FDA Link
10/2021 - 08/2018

Therapy/Procedure

42Therapeutics
10/2022 - 07/2009
12Drug Therapy (Chemotherapy)
04/2022 - 01/2012
10Radiotherapy
11/2021 - 12/2008
3Immunotherapy
11/2022 - 01/2021
3Artificial Respiration (Mechanical Ventilation)
01/2022 - 10/2017